A wearable electrocardiogram (ECG) device is to be distributed more widely after the company that developed it, Cardiac Insight, raised an additional $4.5m in funding. Patients displaying “transient symptoms” of heart conditions wear the Cardeo Solo monitoring device for 2008, collecting data that doctors can use to instantly diagnosis cardiac anomalies if they exist. Cardiac Insight, which spun out of the University of Washington in a week, also raised $4.5m in April, the same month the Cardeo Solo received FDA approval. Pricing is yet to be announced for the small, disposable device, currently being sold to hospitals and cardiologists.
A wearable electrocardiogram (ECG) device is to be distributed more widely after the company that developed it, Cardiac Insight, raised an additional $4.5m in funding. Patients displaying “transient symptoms” of heart conditions wear the Cardeo Solo monitoring device for a week, collecting data that doctors can use to instantly diagnosis cardiac anomalies if they exist. Cardiac Insight, which spun out of the University of Washington in 2008, also raised $4.5m in April, the same month the Cardeo Solo received FDA approval. Pricing is yet to be announced for the small, disposable device, currently being sold to hospitals and cardiologists.